Vanguard Group Inc. Raises Stake in Astrana Health, Inc. (NASDAQ:ASTH)

Vanguard Group Inc. lifted its position in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 0.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,685,959 shares of the company's stock after purchasing an additional 20,757 shares during the period. Vanguard Group Inc. owned about 8.33% of Astrana Health worth $147,748,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Handelsbanken Fonder AB lifted its holdings in Astrana Health by 4.7% during the 4th quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company's stock worth $281,000 after buying an additional 400 shares during the last quarter. Swiss National Bank raised its position in shares of Astrana Health by 1.1% during the 4th quarter. Swiss National Bank now owns 88,444 shares of the company's stock worth $2,789,000 after acquiring an additional 1,000 shares in the last quarter. KBC Group NV lifted its stake in Astrana Health by 108.4% during the fourth quarter. KBC Group NV now owns 2,530 shares of the company's stock worth $80,000 after purchasing an additional 1,316 shares during the last quarter. Quarry LP acquired a new position in Astrana Health in the third quarter valued at approximately $77,000. Finally, Moran Wealth Management LLC increased its stake in Astrana Health by 21.5% in the fourth quarter. Moran Wealth Management LLC now owns 7,944 shares of the company's stock valued at $250,000 after purchasing an additional 1,404 shares during the last quarter. Institutional investors and hedge funds own 52.77% of the company's stock.

Astrana Health Stock Performance

Shares of Astrana Health stock traded up $0.88 during trading hours on Friday, hitting $33.10. 176,494 shares of the company were exchanged, compared to its average volume of 271,142. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. The business has a 50-day moving average of $32.40 and a 200-day moving average of $40.03. Astrana Health, Inc. has a 1 year low of $23.12 and a 1 year high of $63.20. The stock has a market capitalization of $1.66 billion, a price-to-earnings ratio of 25.46, a P/E/G ratio of 1.37 and a beta of 1.04.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) EPS for the quarter, missing analysts' consensus estimates of $0.22 by ($0.37). Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The firm had revenue of $665.21 million for the quarter, compared to analysts' expectations of $617.24 million. As a group, analysts expect that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on ASTH. Macquarie upgraded shares of Astrana Health to a "hold" rating in a report on Monday, December 16th. Bank of America dropped their price objective on Astrana Health from $55.00 to $49.00 and set a "buy" rating on the stock in a report on Tuesday, March 4th. Truist Financial cut their target price on Astrana Health from $50.00 to $46.00 and set a "buy" rating on the stock in a research report on Tuesday, March 18th. Barclays initiated coverage on Astrana Health in a research report on Tuesday, April 1st. They issued an "equal weight" rating and a $36.00 target price for the company. Finally, Stifel Nicolaus cut their price target on Astrana Health from $70.00 to $56.00 and set a "buy" rating on the stock in a research report on Thursday, February 20th. Three equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $53.29.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.